Pages that link to "Item:Q27405"

The following pages link to gender-affirming hormone therapy (Q27405):

Displayed 21 items.

• gender-affirming hormone therapy (Q2083) ‎ (← links)
• Primary care provider beliefs and knowledge of prescribing gender-affirming hormone therapy to transgender and gender diverse patients (Q27410) ‎ (← links)
• Bone health in transgender assigned female at birth people: effects of gender-affirming hormone therapy and gonadectomy (Q27579) ‎ (← links)
• Breast care considerations for transgender and gender-diverse patients (Q27660) ‎ (← links)
• Short-Term Changes in Bone Metabolism Among Transgender Men Starting Gender-Affirming Hormone Therapy: A Systematic Review and Meta-analysis (Q28562) ‎ (← links)
• Assessment of parenteral estradiol and dihydroxyprogesterone use among other feminizing regimens for transgender women: insights on satisfaction with breast development from community-based healthcare services (Q28781) ‎ (← links)
• Evaluating the Risk of Venous Thromboembolism in Transfeminine and Gender Diverse People: A Retrospective Analysis (Q29330) ‎ (← links)
• Safe and supportive prescribing in transgender and non-binary patients with cancer (Q29504) ‎ (← links)
• Gender-affirming hormonal therapy induces a gender-concordant fecal metagenome transition in transgender individuals (Q29540) ‎ (← links)
• Androgen Inhibition of Reproductive Neuroendocrine Function in Females and Transgender Males (Q29604) ‎ (← links)
• Transgender patients and gender-affirming hormone therapy through the mid-life (Q29890) ‎ (← links)
• Glomerular filtration rate estimation in transgender and gender-diverse adults using gender-affirming hormone therapy: an exploratory cross-sectional study (Q30289) ‎ (← links)
• (Q30639) ‎ (← links)
• (Q30726) ‎ (← links)
• (Q30832) ‎ (← links)
• (Q30912) ‎ (← links)
• (Q31140) ‎ (← links)
• (Q31472) ‎ (← links)
• (Q32050) ‎ (← links)
• (Q33547) ‎ (← links)
• (Q33669) ‎ (← links)